Bystander effect in Herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: Role of gap-junctional intercellular communication

Cancer Research

Volumn 60, Issue 15, 2000, Pages 3989-3999

  Mesnil, M ^a   Yamasaki, H ^a  

^a KWANSEI GAKUIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; GANCICLOVIR; PRODRUG; VIRUS VECTOR;

CELL COMMUNICATION; CELL DEATH; DRUG METABOLISM; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SUICIDE GENE; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CELL COMMUNICATION; GANCICLOVIR; GAP JUNCTIONS; GENE THERAPY; HUMANS; PRODRUGS; SIMPLEXVIRUS; THYMIDINE KINASE;

EID: 0033900009     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (167)

1. Leukemia following chemotherapy for ovarian cancer
2. High incidence of secondary brain tumours after radiotherapy and antimetabolites
3. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
4. Potential target found for antimetastasis drugs
5. Therapeutic implications of angiogenesis inhibition
6. Inhibitors of angiogenesis enter Phase III testing
7. Gene replacement strategies for lung cancer
8. Cancer therapy
9. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors
10. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
11. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA
12. Enhanced cytotoxicity of antiviral drugs mediated by adenovirus directed transfer of the herpes simplex virus thymidine kinase gene in rat glioma cells
13. Drug sensitivity ('suicide') genes for selective cancer therapy
14. Human gene therapy comes of age
15. The role of the bystander effect in suicide gene therapy
16. Metabolic co-operation between biochemically marked mammalian cells in tissue culture
17. Novel method for selective killing of transformed rodent cells through intercellular communication, with possible therapeutic applications
18. Nucleotide sequence of the thymidine kinase gene of herpes simplex virus type 1
19. Metabolic activation of the nucleoside analog 9-[(2-hydroxy-1-(hydroxy methyl)ethoxy)methyl]guanine in human diploid fibroblasts infected with human cytomegalovirus
20. 9-[(2-Hydroxy-1-(hydroxy methyl)ethoxy)methyl]guanine: A selective inhibitor of herpes group virus replication
21. 9-[(1,3-Dihydroxy-2-propoxy)-methyl]guanine: A new potent and selective antiherpes agent
22. Anticellular effects of 9-(2-hydroxy-ethoxymethyl)guanine against herpes simplex virus-transformed cells
23. Inhibition of HSV-transformed murine cells by nucleoside analogs, 2'-NDG and 2'-nor-cGMP: Mechanisms of inhibition and reversal by exogenous nucleosides
24. Inhibition by ganciclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information
25. Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2
26. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
27. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene
28. Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities
29. Interaction of herpes simplex virus-induced DNA polymerase with 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate
30. Inhibition of cellular DNA polymerase α and human cytomegalovirus-induced DNA polymerase by the triphosphates of 9-(2-hydroxyethoxymethyl)guanine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine
31. Antiviral activity and mechanism of action of ganciclovir
32. Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound, in Herpes simplex virus-infected cells
33. Intracellular metabolism and enzymatic phosphorylation of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and acyclovir in herpes simplex virus infected and uninfected cells
34. Gene therapy of hepatoma: Bystander effects and non-apoptotic cell death induced by thymidine kinase and ganciclovir
35. The bystander effect: Tumor regression when a fraction of the tumor mass is genetically modified
36. Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells
37. Ganciclovir-induced ablation of non-proliferating thyrocytes expressing herpes thymidine kinase occurs by p53-independent apoptosis
38. Influence of p53 on herpes simplex virus type-1 vectors for cancer gene therapy
39. Superior cytotoxicity with ganciclovir compared with acyclovir and 1-β-D-arabinofuranosylthymine in herpes simplex virus-thymidine kinase-expressing cells: A novel paradigm for cell killing
40. Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration
41. Gene therapy of malignant brain tumors: A rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells
42. Gene therapists test puzzling 'bystander effect'
43. Cancer gene therapy: A bystander effect using the gap junctional pathway
44. Metabolic cooperation between cells
45. Evidence for transfer of enzyme product as the basis of metabolic cooperation between tissue culture fibroblasts of Lesch-Nyhan disease and normal cells
46. Metabolic coupling, ionic coupling and cell contacts
47. The gap junction communication channel
48. Size limit of molecules permeating the junctional membrane channels
49. Hepatocyte gap junctions are permeable to the second messenger, inositol 1,4,5-triphosphate, and to calcium ions
50. Direct isolation and analysis of endogenous transjunctional ADP from Cx43-transfected C6 glioma cells
51. Efficiency of communication between tumour cells in collagen gel cultures
52. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins
53. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro
54. Gap junctions play a role in the 'bystander effect' of the herpes simplex virus thymidine kinase/ganciclovir system in vitro
55. Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes
56. Intercellular communication mediates the bystander effect during herpes simplex thymidine kinase/ganciclovir-based gene therapy of human gastrointestinal tumor cells
57. The bystander effect in the HSV-tk/ganciclovir system and its relationship to gap junctional communication
58. A cell type-specific and gap-junction-independent mechanism for the herpes simplex virus-1 thymidine kinase gene/ganciclovir-mediated bystander effect
59. Lack of bystander killing in herpes simplex virus thymidine kinase-transduced colon cell lines due to deficient connexin43 gap junction formation
60. Long-term survival of immunocompetent rats with intraperitoneal colon carcinoma tumors using herpes simplex thymidine kinase/ganciclovir and IL-2 treatments
61. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo
62. Long-term connexin-mediated bystander effect in highly tumorigenic human cells in vivo in herpes simplex virus thymidine kinase/ganciclovir gene therapy
63. Partial regression, yet incomplete eradication of mammary tumors in transgenic mice by retrovirally mediated HSVtk transfer 'in vivo'
64. Mechanism of 'bystander effect' killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment
65. A tumor suppressor gene, Cx26, also mediates the bystander effect in HeLa cells
66. The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions
67. Actions of HSVtk and connexin43 gene delivery on gap junctional communication and drug sensitization in hepatocellular carcinoma
68. Bystander tumoricidal effect and gap junctional communication in lung cancer cell lines
69. Tentative novel mechanism of the bystander effect in glioma gene therapy with HSV-tk/GCV system
70. Role of connexin genes in growth control
71. Non-communicating human and murine carcinoma cells produce α gap junction mRNA
72. Expression and function of connexin in normal and transformed keratinocytes in culture
73. Intercellular communication and the control of tissue growth: Lack of communication between cancer cells
74. Decreased connexin expression and intercellular communication in human bladder cancer cells
75. Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localisation but not gene mutation of connexin 32
76. Cellular uncoupling in cancerous stomach epithelium
77. Ex-vivo dye transfer assay as an approach to study gap junctional intercellular communication disorders in hepatocarcinogenesis
78. Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues
79. Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumours
80. Analysis of multiple gap junction gene products in the rodent and human mammary gland
81. Connexin expression and gap junctions in the mammary gland
82. Deficiency of connexin43 gap junctions is an independent marker for breast tumors
83. Reduced connexin 43 expression in high grade, human prostatic adenocarcinoma cells
84. Gap junctional intercellular communication and connexin43 expression in human ovarian surface epithelial cells and ovarian carcinomas in vivo and in vitro
85. Connexins are expressed in primary brain tumors and enhance the bystander effect in gene therapy
86. Protein and messenger RNA expression of connexin43 in astrocytomas: Implications in brain tumor gene therapy
87. Inhibition of rat liver gap junctional intercellular communication by tumor-promoting agents in vivo: Association with aberrant localization of connexin proteins
88. Endogenous and exogenous modulation of gap junctional intercellular communication: Toxicological and pharmacological implications
89. Inhibition of cell-cell communication between BALB/c 3T3 cells by tumor promoters and protection by cAMP
90. Transcription of the gene for the gap junctional channel protein connexin 43 and expression of functional cell-to-cell channels are regulated by cAMP
91. Further evidence for the involvement of gap-junctional intercellular communication in induction and maintenance of transformed foci in BALB/c 3T3 cells
92. Retinoids suppress proliferation, induce cell spreading, and up-regulate connexin43 expression only in postconfluent 10T1/2 cells: Implications for the role of gap junctional communication
93. Upregulation of gap junctional communication and connexin43 gene expression by carotenoids in human dermal fibroblasts but not in human keratinocytes
94. Enhancement of liver cell gap junction protein expression by glucocorticoids
95. Apigenin and tengeretin enhance gap junctional intercellular communication in rat liver epithelial cells
96. Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy
97. Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions
98. Cyclic-AMP induction of gap junctional intercellular communication increases bystander effect in suicide gene therapy
99. cAMP stimulates the bystander effect in suicide gene therapy of human choriocarcinoma
100. Hormonal control of cell to cell communication: Regulation by thyrotropin of the gap junction-mediated dye transfer between thyroid cells
101. Cyclic AMP modifies the cellular distribution of connexin43 and induces a persistent increase in the junctional permeability of mouse mammary tumor cells
102. Intercellular communication in rapidly proliferating and differentiated C6 glioma cells in culture
103. Functional and structural assessment of intercellular communication. Increased conduction velocity and enhanced connexin expression in dibutyryl cAMP-treated cultured cardiac myocytes
104. Enhancement of gap junctional intercellular communication by dibutyryl cyclic AMP in lung epithelial cells
105. Gap-junctional communication in normal and neoplastic prostate epithelial cells and its regulation by cAMP
106. Comparison of glucocorticoid-mediated changes in the expression and function of rat hepatocyte gap junctional proteins
107. Coupled induction of exocrine proteins and intracellular compartments involved in the secretory pathway in AR4-2J cells by glucocorticoids
108. Induction and regulation of connexin26 by glucagon in primary cultures of adult rat hepatocytes
109. All-trans retinoic acid enhances gap junctional intercellular communication among renal epithelial cells in vitro treated with renal carcinogens
110. Retinoic acid enhances connexin43 expression at the post-transcriptional level in rat liver epithelial cells
111. Modulation of gap junction expression during transient hyperplasia of rat epidermis
112. Evidence for a posttranscriptional effect of retinoic acid on connexin43 gene expression via the 3'-untranslated region
113. Enhancement of gap junctional communication by retinoids correlates with their ability to inhibit neoplastic transformation
114. The actions of retinoids on cellular growth correlate with their actions on gap junctional communication
115. The role of carotenoids and retinoids in gap junctional communication
116. Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: Relationship to their cancer chemopreventive action
117. Lack of tumor-promoting effects of flavanoids: Studies on rat liver preneoplastic foci and on in vivo and in vitro gap junctional intercellular communication
118. Structure of a gap junction gene: Rat connexin-32
119. Molecular cloning of mouse connexins-26 and -32: Similar genomic organization but distinct promoter sequences of two gap junction genes
120. cAMP delays disappearance of gap junctions between pairs of rat hepatocytes in primary culture
121. Spatiotemporal expression of three gap junction gene products involved in fetomaternal communication during rat pregnancy
122. Multiple gap junction gene products are utilized during rat hair and skin development
123. Connections with connexins: The molecular basis of direct intercellular signalling
124. Regulation of connexin32 and connexin43 gene expression by DNA methylation in rat liver cells
125. 2+ in mouse epidermal cells is controlled by E-cadherin
126. Construction of epithelioid sheets by transfection of mouse sarcoma cells with cDNAs for chicken cell adhesion molecules
127. Gap junction formation between cultured embryonic lens cells is inhibited by antibody to N-cadherin
128. Tumor promoters induce inhibition of gap junctional intercellular communication in mouse epidermal cells by affecting the localization of connexin43 and E-cadherin
129. Inhibition of gap junctional intercellular communication and delocalization of the cell adhesion molecule E-cadherin by tumor promoters
130. The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein
131. Gap junctions and cell polarity: Connexin32 and connexin43 expressed in polarized thyroid epithelial cells assemble into separate gap junctions, which are located in distinct regions of the lateral plasma membrane domain
132. In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: Consequences for HSVtk/GCV anticancer gene therapy
133. Involvement of gap junctions in tumorigenesis: Transfection of tumor cells with connexin 32 cDNA retards growth in vivo
134. Transfection of C6 glioma cells with connexin 43 cDNA: Analysis of expression, intercellular coupling, and cell proliferation
135. Gap junction protein gene suppresses tumorigenicity
136. Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells
137. Innexins: A family of invertebrate gap-junction proteins
138. Innexin-3 forms connexin-like intercellular channels
139. Negative growth control of HeLa cells by connexin genes: Connexin species specificity
140. Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differential potential
141. Transfection of rhabdomyosarcoma cells with connexin43 induced myogenic differentiation
142. Dominant-negative abrogation of connexin-mediated cell growth control by mutant connexin genes
143. Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (Cx43)
144. 1 cell-cycle arrest by the chemopreventive agent apigenin
145. Protection of herpes simplex virus thymidine kinase-transduced cells from ganciclovir-mediated cytotoxicity by bystander cells: The Good Samaritan effect
146. Connexins in tumor suppression and cancer therapy
147. Connexin transfection induces invasive properties in HeLa cells
148. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats
149. Connexin make-up of endothelial gap junctions in the rat pulmonary artery as revealed by immunoconfocal microscopy and triple-label immunogold electron microscopy
150. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene
151. Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors
152. In situ use of suicide genes for cancer therapy
153. Immune system in suicide-gene therapy
154. In vivo analysis of the bystander effect: A cytokine cascade
155. Systemic gene therapy of murine melanoma using tissue specific expression of the HSV-tk gene involves an immune component
156. The 'bystander effect': Association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice
157. Prodrug-activated gene therapy: Involvement of an immunological component in the 'bystander effect.'
158. HSV-tk gene therapy in head and neck squamous cell carcinoma. Enhancement by the local and distant bystander effect
159. Suicide gene therapy for plasma cell tumors
160. Development of systemic immunologic responses against hepatic metastases during gene therapy for peritoneal carcinomatosis with retroviral HS-tk and ganciclovir
161. 'Distant' bystander effect of suicide gene therapy: Regression of nontransduced tumors together with a distant transduced tumor
162. Suicide gene therapy of chemically induced mammary tumors in rat: Efficacy and distant bystander effect